Midgard Science

Labs / Assays & in vitro testing

Harbour BioMed

Shanghai, China · harbourbiomed.com

On your own

Free. Their own form.

Contact Harbour BioMed directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Harbour BioMed is a biopharmaceutical company focused on discovering and developing novel antibody therapeutics. It serves global partners from R&D centers in China, the United States, and Europe, with work spanning antibody discovery platforms, clinical development, and strategic collaborations.

They take quote requests by email.

What they offer

  • Harbour Mice® antibody technology platform

    Generates fully human monoclonal antibodies in H2L2 and heavy chain-only (HCAb) formats.

  • Single Cell Technology Platform

    Provides a full single B cell cloning process including enrichment, separation, screening, sequencing, recombinant antibody production, and verification.

  • HBICE® bispecific antibody technology

    Uses HCAb-based immune cell engagers to generate flexible bispecific formats for different mechanisms of action.

  • HCAb PLUS™ technology

    Provides modality solutions for developing innovative multi-specific medicines across disease areas.

  • Generative AI HCAb Model

    Uses the Hu-mAtrIx™ AI platform to support fully human HCAb model development and accelerate therapy generation.

  • Clinical Development & Medical Services

    Delivers integrated clinical development from first-in-human studies through pivotal registration studies and post-marketing studies.

  • Co-development

    Shares design, execution, and risk of clinical trials with global partners.

  • Technology Service

    Provides technology support through fee-for-service and FTE arrangements.

  • Technology License

    Offers access to the Harbour Mice® platform for external partners.

  • Asset License

    Licenses novel pipelines with potential for global innovation.

  • Strategic Collaboration

    Supports long-term collaboration to develop next-generation therapeutics.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC
Species and models
murine CD138+ plasma cell, single B cell, mammalian display libraries, yeast display libraries, phage display libraries
Assays and studies
single B cell cloning, single B cell separation, antibody binding screening, functional in-chip screening, single-cell antibody sequencing, high-throughput recombinant antibody production, antibody verification
Instruments and platforms
optofluidic technology, next-generation sequencing
Scale and capacity
150+ partners, 400+ projects, 20+ IND/clinical stage, 140+ partners, 380+ projects, over 100 senior scientists
Therapeutic areas
immunology, oncology, immuno-oncology, weight management
Sites
Shanghai, China · Shanghai, China · Beijing, China · Beijing, China · Suzhou, China · Hong Kong, China · Natick, MA, United States of America · Rotterdam, Netherlands
Team
over 100 scientists
Serves
global, China, United States, Europe
Founded
2016

Public records

Ownership
Harbour BioMed Therapeutics Limited · KY GLEIF

Similar labs. Invenra, Sparx BIO, Aurigene Pharmaceutical Services, Kyinno Bio

Found in a contract services directory. Listing built from harbourbiomed.com. Work here? Claim this listing.

Harbour BioMed · Midgard Science